# S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer

> **NCT00182611** · PHASE3 · COMPLETED · sponsor: **Kyoto University** · enrollment: 100 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** tegafur-gimeracil-oteracil potassium
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy

## Key facts

- **NCT ID:** NCT00182611
- **Lead sponsor:** Kyoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2008-09
- **Final completion:** 2008-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182611, "S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00182611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*